脑转移瘤临床试验标准化脑肿瘤影像采集方案的共识推荐
本文基于2019年3月22日美国食品药品监督管理局(FDA)、临床科学家、医药与生物技术公司、临床试验协作组及患者倡导组织的会议讨论,在高级别胶质瘤标准化脑肿瘤影像采集方案(BTIP)基础上制定脑转移瘤方案(BTIP-BM)。文件给出适用于1.5T与3T磁共振系统的最低标准序列及参数,并提供以3T为宜、含动态磁敏感对比灌注的「理想」方案。
要点
- 最低标准序列包括参数匹配的增强前后反转恢复预备各向同性3D T1加权梯度回波。
- 最低标准还包括注射钆对比剂后、增强3D T1加权像前采集轴位2D T2加权快速自旋回波。
- 理想方案以3D Turbo Spin Echo T1加权成像替代反转恢复梯度回波,宜在3T完成并含动态磁敏感对比灌注。
核心结论
- 文件定义了脑转移瘤标准化脑肿瘤影像采集方案(BTIP-BM),以解决中枢神经系统转移瘤评估相关的特殊挑战。
研究设计与样本
- 本文为共识推荐文件,基于2019年3月22日FDA、临床科学家、医药与生物技术公司、临床试验协作组及患者倡导组织的会议讨论制定,并建立在既往高级别胶质瘤标准化脑肿瘤影像采集方案(BTIP)共识推荐之上。
主要发现
- 会议识别的关键问题是为可靠的肿瘤反应评估提供一致的肿瘤测量,第一步是采用可在多中心研究中实施的MRI采集方案实现标准化影像采集。
- 「最低标准」推荐序列包括:(i)参数匹配的增强前后反转恢复(IR)预备、各向同性3D T1加权梯度回波(IR-GRE);(ii)注射钆对比剂后、增强3D T1加权像前采集的轴位2D T2加权快速自旋回波;(iii)轴位2D或3D T2加权液体衰减反转恢复;(iv)轴位2D三方向扩散加权成像;(v)增强2D T1加权自旋回波图像以增加病灶可见性。
- 文件给出1.5T与3T磁共振系统各自的推荐序列参数。
- 「理想」方案以增强前后3D TSE T1加权成像替代IR-GRE,最宜在3T完成,并纳入动态磁敏感对比灌注,文件给出了推荐的灌注参数。
关键数值与推荐
- 「最低标准」推荐的脉冲序列为参数匹配的增强前后IR预备各向同性3D T1加权梯度回波、注射钆对比剂后且增强3D T1加权像前的轴位2D T2加权快速自旋回波、轴位2D或3D T2加权液体衰减反转恢复、轴位2D三方向扩散加权成像、增强2D T1加权自旋回波。
- 「理想」方案以3D TSE T1加权成像替代IR-GRE(增强前后),最宜在3T完成,并包含动态磁敏感对比灌注。
- 文件分别给出1.5T与3T磁共振系统的推荐序列参数及推荐的灌注参数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A recent meeting was held on March 22, 2019, among the FDA, clinical scientists, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocacy groups to discuss challenges and potential solutions for increasing development of therapeutics for central nervous system metastases. A key issue identified at this meeting was the need for consistent tumor measurement for reliable tumor response assessment, including the first step of standardized image acquisition with an MRI protocol that could be implemented in multicenter studies aimed at testing new therapeutics. This document builds upon previous consensus recommendations for a standardized brain tumor imaging protocol (BTIP) in high-grade gliomas and defines a protocol for brain metastases (BTIP-BM) that addresses unique challenges associated with assessment of CNS metastases. The "minimum standard" recommended pulse sequences include: (i) parameter matched pre- and post-contrast inversion recovery (IR)-prepared, isotropic 3D T1-weighted gradient echo (IR-GRE); (ii) axial 2D T2-weighted turbo spin echo acquired after injection of gadolinium-based contrast agent and before post-contrast 3D T1-weighted images; (iii) axial 2D or 3D T2-weighted fluid attenuated inversion recovery; (iv) axial 2D, 3-directional diffusion-weighted images; and (v) post-contrast 2D T1-weighted spin echo images for increased lesion conspicuity. Recommended sequence parameters are provided for both 1.5T and 3T MR systems. An "ideal" protocol is also provided, which replaces IR-GRE with 3D TSE T1-weighted imaging pre- and post-gadolinium, and is best performed at 3T, for which dynamic susceptibility contrast perfusion is included. Recommended perfusion parameters are given.
引用
- Kaufmann TJ, Smits M, Boxerman J, et al. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol. 2020. PMID: 32048719. doi:10.1093/neuonc/noaa030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。